Australia is currently observing the arrival of retatrutide, a novel dual GIP and GLP-1 receptor medication , representing a significant advance in obesity treatment . Early research findings have demonstrated https://giant-talon-bike871053.tnpwiki.com/713673/new_treatment_in_australia_a_promising_solution_for_obesity_management